216
Participants
Start Date
December 7, 2021
Primary Completion Date
June 28, 2024
Study Completion Date
October 14, 2024
Placebo
Oral tablets
Luvadaxistat
Oral tablets
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Plovdiv
Neurocrine Clinical Site, Pleven
Neurocrine Clinical Site, New York
Neurocrine Clinical Site, New York
Neurocrine Clinical Site, Belgrade
Neurocrine Clinical Site, Cedarhurst
Neurocrine Clinical Site, Niš
Neurocrine Clinical Site, Gornja Toponica
Neurocrine Clinical Site, Kovin
Neurocrine Clinical Site, Madrid
Neurocrine Clinical Site, Atlanta
Neurocrine Clinical Site, Pensacola
Neurocrine Clinical Site, Miami
Neurocrine Clinical Site, Miami
Neurocrine Clinical Site, Miami
Neurocrine Clinical Site, Miami
Neurocrine Clinical Site, Aventura
Neurocrine Clinical Site, Tampa
Neurocrine Clinical Site, Kragujevac
Neurocrine Clinical Site, Okeechobee
Neurocrine Clinical Site, Flowood
Neurocrine Clinical Site, Ann Arbor
Neurocrine Clinical Site, Chicago
Neurocrine Clinical Site, St Louis
Neurocrine Clinical Site, St Louis
Neurocrine Clinical Site, Bryant
Neurocrine Clinical Site, Bentonville
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston
Neurocrine Clinical Site, Phoenix
Neurocrine Clinical Site, Torrance
Neurocrine Clinical Site, Pico Rivera
Neurocrine Clinical Site, Bellflower
Neurocrine Clinical Site, Glendale
Neurocrine Clinical Site, Oceanside
Neurocrine Clinical Site, San Diego
Neurocrine Clinical Site, San Diego
Neurocrine Clinical Site, Anaheim
Neurocrine Clinical Site, Garden Grove
Neurocrine Clinical Site, Stanford
Neurocrine Clinical Site, San Rafael
Neurocrine Clinical Site, Pilsen
Neurocrine Clinical Site, Prague
Neurocrine Clinical Site, Prague
Lead Sponsor
Neurocrine Biosciences
INDUSTRY